/Companies

Microplate Dx

Glasgow, GB · Founded 2021 · Incorporated in United Kingdom · 5 known investors

Find your way into Microplate Dx

Each arrow is one introduction. Sign up to fill in the first one.

114 people can intro you to Dr

Ask Peter Proud FRSE to introduce you to Dr Stuart Hannah

You →Peter · together at Royal Society of Edinburgh →Dr

Sign up to find every way you can get introduced to Microplate Dx

  • Your email: who you already know at Microplate Dx, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Microplate Dx team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Microplate Dx is a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify the correct antibiotic treatment for infections within hours, enabling faster patient treatment and reducing antibiotic resistance. The company targets healthcare providers and focuses on improving clinical outcomes in infectious disease management.

Founders & leadership

Microplate Dx was founded in 2021 by Dr Stuart Hannah.

DSDr Stuart Hannah
Dr Stuart HannahCo-Founder & CEODr. Stuart Hannah is co-founder and CEO of Microplate Dx, a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify appropriate antibiotic treatments for infections.

Board

PM
Poonam MalikBoard director
AJ
Andrew Justin Radcliffe PorterBoard director

Investors · 5

Also in the syndicate · 3

SIS VenturesThairm BioUniversity of Strathclyde

Funding

SEC filings, press & company announcements

$2.1M disclosed across 2 of 3 rounds · 2022–2025

▶$644.6KraisedSep 2025 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew Justin Radcliffe PorterDirector
  • Stuart Matthew HannahExecutive Officer, Director
  • Poonam MalikExecutive Officer, Director
Amount sold
$644.6K
First sale
Sep 2025
Incorporated
Other, United Kingdom, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedJul 2023 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MBM SECRETARIAL SERVICES LIMITEDExecutive Officer
  • Poonam MalikDirector
  • Andrew Justin Radcliffe PorterDirector
  • Stuart Matthew HannahDirector
Amount sold
$1.4M
First sale
Jul 2023
Incorporated
Other, United Kingdom, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Companies working in the same space as Microplate Dx.

Companies House · registry record

View on Companies House ↗
Registered name
MICROPLATE DX LIMITED
Company number
SC706330
Status
Active
Company type
Private limited company
Incorporated
10 Aug 2021
Registered office
Suite 534 Royal College Building, 204 George Street, Glasgow, G1 1XW
Nature of business (SIC)
74909 — Other professional, scientific and technical activities n.e.c.
Accounts
last made up to 30 Apr 2025 · next due 31 Jan 2027
Confirmation statement
last made up to 9 Aug 2025 · next due 23 Aug 2026

Current officers · 6

  • Mbm Secretarial Services Limited — corporate secretary, appointed 29 Mar 2023
  • Nicola Broughton — director, appointed 1 Jul 2026
  • Stuart Matthew Hannah — director, appointed 10 Aug 2021
  • Poonam Malik — director, appointed 10 Aug 2021
  • Andrew Justin Radcliffe Porter — director, appointed 7 Mar 2022
  • Michael Rasche — director, appointed 18 Apr 2026

Source: Companies House public register · retrieved 6 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.

In the news

Frequently asked questions

What does Microplate Dx do?
Microplate Dx is a diagnostics company developing rapid antimicrobial susceptibility testing technology to identify the correct antibiotic treatment for infections within hours, enabling faster patient treatment and reducing antibiotic resistance. The company targets healthcare providers and focuses on improving clinical outcomes in infectious disease management.
Who founded Microplate Dx?
Microplate Dx was founded by Dr Stuart Hannah in 2021.
Who are Microplate Dx's investors?
Microplate Dx's investors include Deepbridge Capital, Scottish Enterprise.
How much funding has Microplate Dx raised?
Microplate Dx has disclosed $2.1M raised across 2 of its 3 known rounds.
Where is Microplate Dx headquartered?
Microplate Dx is headquartered in Glasgow, GB.